MedTrace Logo

Feasibility of Teleglaucoma Versus Conventional Clinical Evaluation for Diagnostic Accuracy and Management Recommendations in Patients With Glaucoma

NCT03587454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2021-08-23

No results posted yet for this study

Summary

Telemedicine allows screening of subjects with limited access to eye care. Failure of screenees to come for full examination was identified as a serious problem. Teleglaucoma should allow a single physician access to screenees in real time. The investigators aim to test the technical feasibility of developing a system for teleglaucoma that will allow a physician real time access to patient information and images and compare it to traditional physical presence evaluation in glaucoma clinics. This system can be applied during telemedicine for glaucoma and other vision threatening diseases.

Conditions

  • Teleglaucoma
  • Teleophthalmology
  • Glaucoma

Interventions

DIAGNOSTIC_TEST

Teleglaucoma

Subjects are evaluated through a teleglaucoma protocol then by physical presence in a glaucoma clinic

Sponsors & Collaborators

  • New Jersey Health Foundation

    collaborator OTHER

  • Rutgers University

    lead OTHER

Principal Investigators

  • Albert S Khouri, MD · Rutgers University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-09-01
Completion
2019-09-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587454 on ClinicalTrials.gov